Worth reading
43Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Mixed performance
Direction inferred from the company’s description.Scale
32.8
% (year-on-year change in revenue)Wording
Conditional
How definitive the wording is.Results for this period
Full year1 October 2023–30 September 2024ConsolidatedJapanese GAAPNet Sales42,475¥ millionYear on year +32.8%Progress 79.2%
Operating profit10,612¥ millionYear on year +23.0%Progress 123.0%
Ordinary income10,551¥ millionYear on year +23.5%Progress 127.7%
Net income attributable to owners of the parent7,438¥ millionYear on year +17.9%Progress 128.2%
The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
Net income per share75.86円
Operating Margin25.0%
Financial position at period-end
Total assets71,799¥ million
of which net assets 33,212 ¥ millionEquity ratio 46.3%vs. prior year-end -1.4pt
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Cash inflows and outflows
Operating+7,484
Investment-16,828
Financials+6,083
Net change-3,261
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Cash and cash equivalents at end of period¥8,868 million
Outlook and shareholder returns
Full-year earnings forecast
Net Sales¥53,647 million (YoY +26.3%)
Operating profit¥8,627 million (YoY -18.7%)
Ordinary income¥8,265 million (YoY -21.7%)
Net income¥5,804 million (YoY -22.0%)
Annual Dividend Forecast¥3 → ¥4（+33.3%）
Payout ratio2024年９月期 5.3% / 2025年９月期予想 6.7%
Factors Behind Changes in Business Performance
医心館事業で28事業所を新規開設し、1事業所を増床してサービスを提供した。今後も積極的な事業所開設と医療機関等への営業活動を進める。
Disclosure regarding the going concern assumption
No applicable matters.
Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 No修正再表示 No
Changes in the scope of consolidation新規0社、除外0社、社名なし（期中における連結範囲の重要な変更：無）
Material subsequent eventsNo applicable matters.
Depreciation and amortization¥1,848 million
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingAvailable (for institutional investors and analysts)
Issued Shares at Period-End98,112,000 shares
Treasury Shares at Period-End252,856株
| Item | Details |
|---|---|
| Fiscal Period Classification | Full year |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 October 2023–30 September 2024 |
| Net Sales | ¥42,475 million (YoY +32.8%) |
| Operating profit | ¥10,612 million (YoY +23.0%) |
| Ordinary income | ¥10,551 million (YoY +23.5%) |
| Profit attributable to owners of the parent | ¥7,438 million (YoY +17.9%) |
| Net income per share | 75.86円 |
| Operating Margin | 25.0% |
| Equity ratio | End of the current fiscal period 46.3% / End of previous period 47.7% |
| Total assets | ¥71,799 million |
| Net assets | ¥33,212 million |
| Cash flows from operating activities | ¥7,484 million |
| Cash flows from investing activities | ¥-16,828 million |
| Cash flows from financing activities | ¥6,083 million |
| Cash and cash equivalents at end of period | ¥8,868 million |
| Full-year earnings forecast | Net Sales ¥53,647 million (YoY +26.3%) / Operating profit ¥8,627 million (YoY -18.7%) / Ordinary income ¥8,265 million (YoY -21.7%) / Net income ¥5,804 million (YoY -22.0%) |
| Annual Dividend Forecast | ¥3 → ¥4（+33.3%） |
| Payout ratio | 2024年９月期 5.3% / 2025年９月期予想 6.7% |
| Depreciation and amortization | ¥1,848 million |
| Disclosure regarding the going concern assumption | No applicable matters. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | 新規0社、除外0社、社名なし（期中における連結範囲の重要な変更：無） |
| Material subsequent events | No applicable matters. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Available (for institutional investors and analysts) |
| Issued Shares at Period-End | 98,112,000 shares |
| Treasury Shares at Period-End | 252,856株 |
| Factors Behind Changes in Business Performance | 医心館事業で28事業所を新規開設し、1事業所を増床してサービスを提供した。今後も積極的な事業所開設と医療機関等への営業活動を進める。 |
Items this document does not state (8)
Revision to Earnings ForecastShareholder Return PolicySegment revenueSegment profitRegional salesOrders received and order backlogImpairment lossBreakdown of extraordinary income (loss)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.当期は医心館事業で28事業所を新規開設し、1事業所を増床したこと、医療機関等への営業活動を挙げている。2025年9月期は28事業所の新規開設と1事業所の増床を見込んでいるが、営業利益が減少する個別の理由は示していない。
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.